Ticker Details
Upstream Bio, Inc. Common Stock
IPO Date:	October 11, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$425.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.71 | 4.44%
Avg Daily Range (30 D):	$0.21 | 2.99%
Avg Daily Range (90 D):	$0.26 | 3.13%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.53M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	70
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	469
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$.96M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.65M
Avg Closing Trade (30 D):	$1M
Avg Closing Trade (90 D):	$1.17M
Avg Closing Volume:	112.56K

News

Apr 23, 2026 @ 5:00 PM Chronic Obstructive Pulmonary Disease Clinical Tri... Source: Delveinsight

Apr 7, 2026 @ 5:00 PM Severe Asthma Clinical Trial Pipeline Appears Robu... Source: Delveinsight

Apr 7, 2026 @ 11:02 AM From Lungs To Nasal Polyps: Sanofi Finds Success W... Source: Vandana Singh

Mar 1, 2026 @ 2:45 PM Upstream Bio Presents Additional Analyses from the... Source: Upstream Bio, Inc.

Feb 26, 2026 @ 12:00 PM Upstream Bio to Present Additional Analyses from P... Source: Upstream Bio, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.9	$-.75	$-.78
Diluted EPS	$-2.9	$-.75	$-.78
Revenue	$3.32M	$1.03M	$.67M
Gross Profit
Net Income / Loss	$-156.76M	$-40.59M	$-42.46M
Operating Income / Loss	$-171.96M	$-43.62M	$-46.17M
Cost of Revenue
Net Cash Flow	$25.41M	$-4.85M	$29.41M
PE Ratio